Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer

Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer

Objective: To assess the activity and toxicity of cisplatin and irinotecan alternating with docetaxel in patients with advanced non-small cell lung cancer (NSCLC). Material and Method: Eligibility included chemo-naïve stage IIIB with malignant effusion and stage IV NSCLC patients with measurable dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Chaiyut Charoentum, Sumitra Thongprasert, Busayamas Chewasakulyong, Juntima Euathrongchit, Sirikul Sorraritchingchai, Sutthirak Munprakan
Format: Journal
Published: 2018
Subjects:
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=37149053450&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/61239
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=37149053450&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/61239

Similar Items